Navigation Links
Big Arrow Group Expands Global Capabilities with Addition of Anne de Schweinitz
Date:2/12/2009

NEW YORK, Feb. 12 /PRNewswire/ -- Big Arrow Group, a New York-based full-service strategic consulting and communications firm, today announced that Anne de Schweinitz has joined the company.

As a member of Big Arrow's leadership team, Ms. de Schweinitz will be responsible for driving business growth by ensuring the success of current client programs and by expanding Big Arrow's offerings and expertise, especially in the area of global pharmaceutical and healthcare consulting.

Ms. de Schweinitz brings deep experience in healthcare marketing and communications to Big Arrow Group. She joins the firm following nearly 10 years at MS&L, a global communications agency within the Publicis Groupe of companies, where she served most recently as senior vice president and global account director for the agency's largest healthcare client, Eli Lilly and Company. In addition to overseeing teams in North American and Europe working in the areas of diabetes, cardiovascular disease, women's health and erectile dysfunction, Anne worked closely with Lilly's U.S. and global brand teams to help align and reposition the company's broad offering in diabetes.

"Success as a global account director for major companies and brands, especially in highly regulated industries, requires exceptional strategic insight and creative savvy. Anne has built an excellent reputation as a trusted advisor to her clients, helping them address their most critical business needs through highly differentiated and influential communications programs," said Mike Marino, president and founder of Big Arrow Group.

Prior to joining MS&L's New York office in 2006, Ms. de Schweinitz held positions in San Francisco and London, where she led the agency's global accounts for sanofi-aventis as well as programs on behalf of numerous pharmaceutical, biotech, medical device and healthcare delivery companies in a wide range of therapeutic areas.

Before joining MS&L, Ms. de Schweinitz work for the University of California, San Francisco, where she helped drive internal communications and supported public relations activities for corporate, clinical and research news. She is a Phi Beta Kappa graduate of Rutgers University and is active in a number of community and arts organizations in the New York area.

About Big Arrow Group

Big Arrow Group is a full-service strategic consulting and communications firm specializing in global brand development, marketing planning and integrated communications, new product development and market research. The firm has redefined communications deliverables through research and case-tested strategies to provide their clients with practical, easily activated strategies that build and accelerate brand momentum. Founded in 2004, Big Arrow Group is headquartered in New York City.

Big Arrow Group provides strategic planning and corporate brand development in technology, healthcare, pharmaceutical and business-to-business for a wide range of clients, including Biocodex, Genzyme Corporation, Northeast Utilities and Bayer Schering Pharma. To learn more about the Big Arrow Group, please visit http://www.bigarrowgroup.com.


'/>"/>
SOURCE Big Arrow Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
3. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
4. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
5. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
6. Arrow International Announces Annual Meeting Voting Results
7. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
9. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
10. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
11. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... US ... Yoga Studio in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio ... seacoast, just one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses ...
(Date:2/5/2016)... ... 2016 , ... Give To Cure today announced that it is ... Give To Cure’s campaign that is crowdfunding clinical trials to help find cures faster ... through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. ... Annual No Cost Dental Day to individuals in need. The event is scheduled to ... No Cost Dental Day is to provide dental care to community members in need. ...
(Date:2/5/2016)... Pekin, IL (PRWEB) , ... February 05, 2016 , ... ... in disguised form as a dream. A hallmark feature of patients with eating disorders ... and needs. The eating disorder behaviors and obsessions are regarded as maladaptive means for ...
(Date:2/5/2016)... ... , ... Calls Blacklist has just been updated by mobile app developer Vlad ... has fixed known bugs within the app. Calls Blacklist allows its users to only ... any of their device’s battery power or memory. It provides a powerful call blocker ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: